Disease-Modifying Therapy in Dementia

Disease-Modifying Therapy in Dementia

March 2019 – Vol.21 – No.1

Download this issue

Editorial

Is dementia a preventable disease?
Michael Davidson, MD; Florence Thibaut, MD, PhD, Editor in Chief

State of the art

Is Alzheimer disease a failure of mobilizing immune defense? Lessons from cognitively fit oldest-old
Pavel Katsel, PhD; Vahram Haroutunian, PhD (USA)

Original articles

Potential immunotherapy for Alzheimer disease and age-related dementia
Michal Schwartz, PhD; Michal Arad, PhD; Hila Ben-Yehuda, PhD (Israel)
 
What are we trying to prevent in Alzheimer disease?
Frank Jessen, MD (Germany)
 
Cognitive stimulation, training, and rehabilitation
Alexander Kurz, MD, PhD (Germany)
 
Dementia treatment versus prevention
Robert Perneczky, MRCPsy, MBA (Germany)
 
Dementia prevention and reserve against neurodegenerative disease
Robert Perneczky, MRCPsy, MBA (Germany)
 
Physical activity for cognitive health: what advice can we give to older adults with subjective cognitive decline and mild cognitive impairment?
Nicola T. Lautenschlager, MD; Kay L. Cox, PhD; Kathryn A. Ellis, PhD (Australia)
 
Dietary interventions in mild cognitive impairment and dementia
George S. Vlachos, MD; Nikolaos Scarmeas, MD, PhD (Greece, USA)
 
Antidiabetic therapies and Alzheimer disease
Barbara B. Bendlin, PhD (USA)
 
Prevention of dementia presents a potentially critical platform for improvement of long-term public health
Michal Schnaider Beeri, PhD (Israel, USA)
 
Ethical issues in early diagnosis and prevention of Alzheimer disease
Peter J. Whitehouse, MD, MA (Bioethics), PhD (USA)